Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessment.

Yuki TahataRyotaro SakamoriAyako UrabeRyoko YamadaKazuyoshi OhkawaNaoki HiramatsuHideki HagiwaraMasahide OshitaTaizo HijiokaShinji TamuraYasuharu ImaiTakahiro Kodama Hayato HikitaTomohide TatsumiTetsuo Takehara

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2020)

HCC occurrence in sustained virologic response patients does not differ between IFN-based and IFN-free treatment considering liver fibrosis stage. The degree of its progress at diagnosis does not differ between the two groups.

Keyphrases

dendritic cells
liver fibrosis
risk assessment
immune response
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hiv infected
patient reported